iRay Group (SHA:688301)

China · Delayed Price · Currency is CNY

96.44

-8.76 (-8.33%)

Jul 13, 2026, 2:25 PM CST

52.32% (1Y)

Market Cap	31.13B +75.3%
Revenue (ttm)	2.46B +34.8%
Net Income	685.66M +46.2%
EPS	2.28 +38.7%
Shares Out	295.90M
PE Ratio	46.05
Forward PE	36.74
Dividend	0.71 (0.68%)
Ex-Dividend Date	Jun 12, 2026

Volume	10,211,994
Open	104.78
Previous Close	105.20
Day's Range	96.33 - 105.50
52-Week Range	59.68 - 153.29
Beta	0.79
Analysts	Buy
Price Target	111.81 (+15.94%)
Earnings Date	Aug 14, 2026

About iRay Group

iRay Group, together with its subsidiaries, researches, develops, produces, sells, and services x-ray system components and micro-display backplanes for use in medical, dental, oncology, veterinary, security, and nondestructive testing applications in China and internationally. The company offers wireless and tethered radiography, mammography, and dynamic/real-time detectors; linear detector arrays; X-ray and micro focus X-ray sources; high voltage generators; radiation detecting materials; software; and other products. It is also involved in t... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 2011

Employees 2,292

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688301

Full Company Profile

Financial Performance

In 2025, iRay Group's revenue was 2.25 billion, an increase of 22.90% compared to the previous year's 1.83 billion. Earnings were 650.01 million, an increase of 39.73%.

Financial Statements

Analyst Summary

According to 8 analysts, the average rating for 688301 stock is "Buy." The 12-month stock price target is ¥111.81, which is an increase of 15.94% from the latest price.

Price Target

¥111.81

(15.94% upside)

Analyst Consensus: Buy

Stock Forecasts